1. Home
  2. KRYS vs PJT Comparison

KRYS vs PJT Comparison

Compare KRYS & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • PJT
  • Stock Information
  • Founded
  • KRYS 2015
  • PJT 2014
  • Country
  • KRYS United States
  • PJT United States
  • Employees
  • KRYS N/A
  • PJT N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • PJT Investment Managers
  • Sector
  • KRYS Health Care
  • PJT Finance
  • Exchange
  • KRYS Nasdaq
  • PJT Nasdaq
  • Market Cap
  • KRYS 4.7B
  • PJT 3.9B
  • IPO Year
  • KRYS 2017
  • PJT N/A
  • Fundamental
  • Price
  • KRYS $196.65
  • PJT $166.78
  • Analyst Decision
  • KRYS Strong Buy
  • PJT Hold
  • Analyst Count
  • KRYS 9
  • PJT 3
  • Target Price
  • KRYS $214.22
  • PJT $193.50
  • AVG Volume (30 Days)
  • KRYS 316.5K
  • PJT 244.2K
  • Earning Date
  • KRYS 11-03-2025
  • PJT 11-04-2025
  • Dividend Yield
  • KRYS N/A
  • PJT 0.60%
  • EPS Growth
  • KRYS 275.72
  • PJT 72.80
  • EPS
  • KRYS 6.66
  • PJT 6.53
  • Revenue
  • KRYS $373,164,000.00
  • PJT $1,657,789,000.00
  • Revenue This Year
  • KRYS $34.33
  • PJT $11.42
  • Revenue Next Year
  • KRYS $48.04
  • PJT $12.18
  • P/E Ratio
  • KRYS $29.71
  • PJT $25.52
  • Revenue Growth
  • KRYS 54.51
  • PJT 23.30
  • 52 Week Low
  • KRYS $122.80
  • PJT $119.76
  • 52 Week High
  • KRYS $212.98
  • PJT $190.28
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 59.19
  • PJT 40.77
  • Support Level
  • KRYS $194.92
  • PJT $158.77
  • Resistance Level
  • KRYS $212.98
  • PJT $169.82
  • Average True Range (ATR)
  • KRYS 8.35
  • PJT 6.17
  • MACD
  • KRYS -0.17
  • PJT -0.83
  • Stochastic Oscillator
  • KRYS 42.14
  • PJT 29.78

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

Share on Social Networks: